Biomarker Could Help ID Fibromyalgia

Biomarker Could Help ID Fibromyalgia
Fibromyalgia (FM) is a painful disorder that healthcare providers in the past have sometimes failed to recognize as an actual medical condition. It is characterized by widespread pain of unknown origin, and can be hard to tell apart from other conditions like arthritis. bloodA new study, titled "Mucosal-Associated Invariant T Cell Is a Potential Marker to Distinguish Fibromyalgia Syndrome from Arthritis" has been published in the journal PloS One. It could mean good news for those suffering from FM. Researchers from Sapporo, Japan have found a biomarker that could distinguish FM from arthritis, helping direct patients to the right treatments and legitimizing FM as a true biological condition. A biomarker refers to something that can be measured in a person's biology to distinguish a disease from a healthy state. Biomarkers are often used to measure responses to treatment. Proteins found in the blood can serve as biomarkers. The investigators used blood samples to try to find biomarker molecules that are different in people with FM when compared to people who have the related and often co-occurring conditions, rheumatoid arthritis and spondyloarthritis. They focused on a type of cell called mucosal-associated invariant T (MAIT). Led by Chie Sugimoto of the Department of Hygiene
Subscribe or to access all post and page content.